0001165527-12-000803.txt : 20120904 0001165527-12-000803.hdr.sgml : 20120903 20120806101406 ACCESSION NUMBER: 0001165527-12-000803 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PN Med Group Inc CENTRAL INDEX KEY: 0001549084 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047] IRS NUMBER: 990367049 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: SAN ISIDRO 250, DEPTO 618 CITY: SANTIAGO STATE: F3 ZIP: 8240400 BUSINESS PHONE: 569-659-22350 MAIL ADDRESS: STREET 1: SAN ISIDRO 250, DEPTO 618 CITY: SANTIAGO STATE: F3 ZIP: 8240400 CORRESP 1 filename1.txt PN MED GROUP INC. San Isidro 250, depot 618, Santiago, Chile 8240400 Tel: 569-659-22350 Fax: 775-981-9001 Email: pnmedgroup@gmail.com -------------------------------------------------------------------------------- August 6, 2012 Mr. H. Roger Schwall, Assistant Director U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Re: PN Med Group Inc. Amendment No. 4 to Registration Statement on Form S-1 Filed July 11, 2012 File No. 333-181229 Dear Mr. Schwall: This letter shall serve as the request of PN Med Group Inc., pursuant to Rule 461, to accelerate the effectiveness of the above-referenced Registration Statement to Monday, August 6, 2012, 4:30PM EST, or the soonest practicable date thereafter. The Company further acknowledges the following: * Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; * The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and * The Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Sincerely, /s/ Pedro Perez Niklitschek ------------------------------------- Pedro Niklitschek President & Director